These results demonstrated that the adverse impact of obesity on colorectal cancer relapse and mortility was limited to patients with tumor of reduced NDRG4 expression, indicating that NDRG4 might correlate to patients' carcinogenesis and energy metabolism in determination of colorectal cancer clinical outcome. The gene discussed is NDRG4; the disease is colorectal cancer.